What is Torrent Pharmaceuticals Ltd's PE ratio?

Torrent Pharmaceuticals Ltd trades at a P/E ratio of 82.80.

What is Torrent Pharmaceuticals Ltd's market cap?

Torrent Pharmaceuticals Ltd's market capitalisation is ₹1.85L Cr.

When did Torrent Pharmaceuticals Ltd last report results?

Torrent Pharmaceuticals Ltd last reported Q1FY27 results on 30 Jul '26.

What is Torrent Pharmaceuticals Ltd's ROE?

Torrent Pharmaceuticals Ltd's return on equity (ROE) is 27.4%.

What sector is Torrent Pharmaceuticals Ltd in?

Torrent Pharmaceuticals Ltd (TORNTPHARM) is classified in the Healthcare sector (Pharmaceuticals).

Healthcare · Pharmaceuticals

Torrent Pharmaceuticals Ltd (TORNTPHARM)

₹4,914.00

Mkt cap

₹1.85L Cr

P/E ratio

82.80

P/B

19.81

Div yield

0.78%

ROE

27.40%

ROCE

15.20%

EPS (TTM)

₹59.35

Book value

₹248

52W range

3,515–5,123

Sector

Healthcare

Price history

Previous close

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. [1] It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses. [2]

NSE TORNTPHARMBSE 500420

Health check

Mixed

ValuationExpensive

ProfitabilityStrong

GrowthModerate

TechnicalsNeutral

52-week range

−4.08% from high

₹4,914

₹3,515+39.81% from low₹5,123

Current

₹4,914.00

Prev close

₹4,857.00

Day

+1.17%

Price performance

+1.17%

−3.00%

−0.20%

+9.86%

+13.20%

+37.10%

YTD

+26.48%

Financials

Revenue, profit & margin

P/E ratio

82.8×

TORNTPHARM is 144% above the sector median of 34.0×

TORNTPHARM82.8×

Sector median34.0×

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	2,591	2,660	2,732	2,745	2,859	2,889	2,809	2,959	3,178	3,302	3,303	4,197	4,921
Expenses	1,800	1,835	1,863	1,862	1,955	1,950	1,895	1,995	2,146	2,219	2,215	2,841	3,257
Operating Profit	791	825	869	883	904	939	914	964	1,032	1,083	1,088	1,356	1,664
OPM %	31%	31%	32%	32%	32%	32%	33%	33%	32%	33%	33%	32%	34%
Other Income	34	26	55	31	24	-16	33	-42	-37	-40	-23	-83	-33
Interest	103	91	80	80	75	64	57	56	56	48	45	236	305
Depreciation	191	201	213	203	197	198	199	201	201	204	206	508	593
Profit before tax	531	559	631	631	656	661	691	665	738	791	814	529	733
Tax %	29%	31%	30%	29%	30%	31%	27%	25%	26%	25%	22%	31%	23%
Net Profit	378	386	443	449	457	453	503	498	548	591	635	364	566
EPS in Rs	11.17	11.41	13.09	13.27	13.50	13.38	14.86	14.71	16.19	17.46	18.76	10.76	16.72
Raw PDF

Earnings

Results dates & reactions

No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +0.67% · closed higher next day 31 of last 66

	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25	Q4FY25†	Q1FY26	Q2FY26	Q3FY26	Q4FY26	Q1FY27
Broadcast	25 Oct '23	2 Feb '24◦	24 May '24◦	23 Jul '24◦	25 Oct '24◦	24 Jan '25◦	20 May '25◦	28 Jul '25◦	7 Nov '25◦	13 Feb '26◦	22 May '26◦	30 Jul '26◦
Earnings day	+2.39%	+4.67%	+1.63%	+0.23%	−3.38%	+2.75%	+1.47%	+4.01%	+6.63%	+4.50%	+1.93%	+5.15%
+1 day	+0.66%	+3.37%	+2.07%	−1.70%	−6.33%	+2.04%	−0.91%	+2.97%	+6.87%	+4.42%	−0.76%	+3.65%
+5 days	+2.28%	+3.72%	+2.50%	+1.05%	−7.24%	−1.25%	−2.33%	−0.93%	+6.69%	+5.63%	−3.75%	+1.07%
+15 days	+8.64%	+3.90%	+10.50%	+6.69%	−9.64%	−7.22%	−1.10%	+1.13%	+4.38%	+8.58%	−0.43%	+0.50%
+30 days	+9.38%	−0.96%	+12.38%	+9.68%	−3.06%	−5.46%	+3.33%	−1.08%	+6.59%	−2.23%	+8.47%	—
Filing	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	PDF	PDF	XBRL	XBRL	XBRL

Corporate actions

Last 6 months

Kind	Value	Ex-date	Record
dividend Dividend - Rs 9 Per Share	9.00	29 May '26	29 May '26

Results analysis

Shareholding

as of Jul 2026

60.78%Promoter

Promoters60.78%7.53

FIIs17.97%2.53

DIIs12.77%3.04

Public8.39%1.97

Government0.09%0.01

Ownership trend

Peers

7 companies

Valuation vs quality

P/E × ROCE · bubble = market cap

Name	CMP	P/E	Mkt Cap	Div Yld	NP Qtr	Qtr Profit Var	Sales Qtr	Qtr Sales Var	ROCE
SUNPHARMA	₹1,899.00	36.07	4,55,634	0.84%	2,901	+5.95%	15,300	+10.46%	20.53%
DIVISLAB	₹9,100.00	81.09	2,41,576	0.33%	902	+65.50%	3,080	+27.80%	21.97%
TORNTPHARM	₹4,857.00	82.80	1,84,745	0.78%	566	+5.79%	4,921	+54.85%	15.19%
CIPLA	₹1,385.00	31.26	1,11,888	0.94%	786	−39.19%	7,119	+2.33%	15.49%
ZYDUSLIFE	₹1,120.00	22.95	1,11,720	0.09%	990	−35.09%	8,017	+21.96%	21.14%
LAURUSLABS	₹1,840.00	90.93	99,417	0.11%	362	+125.49%	2,026	+29.10%	17.76%
LUPIN	₹2,110.00	16.20	96,483	0.85%	1,417	+16.08%	8,277	+32.04%	29.93%
Median: 158 Co.	₹421.50	33.96	2,277	0.08%	13	+30.25%	164	+18.67%	14.96%

Filings

Annual reports15

Annual Report 2026bse Annual Report 2025bse Annual Report 2024bse Annual Report 2023bse Annual Report 2022bse Annual Report 2021bse Annual Report 2020bse Annual Report 2019bse Annual Report 2018bse Annual Report 2017bse Annual Report 2016bse Annual Report 2015bse Annual Report 2014bse Annual Report 2013bse Annual Report 2012bse

Credit ratings6

Rating update 21 Julicra Rating update 5 Janicra Rating update 2 Janfitch Rating update 6 Oct 2025fitch Rating update 8 Jul 2025icra Rating update 19 Mar 2025icra

Announcements5

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 11 Aug - Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (LODR) Regulations, 2015 Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - ESG Rating 11 Aug - NSE Sustainability Ratings assigned Torrent Pharmaceuticals an ESG rating of 70.Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Aug - Newspaper Advertisement for completion of dispatch of Postal Ballot Notice Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 5 Aug Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 4 Aug - Transcript of Q1 FY26-27 analyst conference call posted on company website.